Holen Sie sich die Stockscreener-App
15.41
0.26%
0.04
Handel nachbörslich:
15.58
0.17
+1.10%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TNDM?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$15.37
Offen:
$15.46
24-Stunden-Volumen:
1.32M
Relative Volume:
0.57
Marktkapitalisierung:
$1.06B
Einnahmen:
$1.03B
Nettoeinkommen (Verlust:
$-94.55M
KGV:
-11.00
EPS:
-1.4012
Netto-Cashflow:
$-3.64M
1W Leistung:
+0.59%
1M Leistung:
-5.05%
6M Leistung:
-28.99%
1J Leistung:
-4.70%
1-Tages-Spanne:
$15.00
$15.50
1-Wochen-Bereich:
$14.80
$15.86
52-Wochen-Spanne:
$9.98
$29.65
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
Firmenname
Tandem Diabetes Care Inc
Sektor
Branche
Telefon
858-366-6900
Adresse
12400 HIGH BLUFF DRIVE, San Diego, CA
Compare TNDM vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
15.41 | 1.06B | 1.03B | -94.55M | -3.64M | -1.4012 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-19 | Hochstufung | Truist | Hold → Buy |
| 2026-03-17 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2026-02-23 | Hochstufung | Lake Street | Hold → Buy |
| 2026-02-20 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2026-01-27 | Fortgesetzt | TD Cowen | Buy |
| 2025-12-16 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-10-21 | Fortgesetzt | Stifel | Hold |
| 2025-09-08 | Eingeleitet | Oppenheimer | Outperform |
| 2025-08-12 | Hochstufung | Citigroup | Sell → Neutral |
| 2025-08-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-07-09 | Herabstufung | Citigroup | Neutral → Sell |
| 2025-06-16 | Eingeleitet | Truist | Hold |
| 2025-04-10 | Eingeleitet | Mizuho | Neutral |
| 2025-03-05 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-03-03 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-02-28 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-06 | Eingeleitet | Bernstein | Outperform |
| 2024-10-04 | Eingeleitet | Goldman | Neutral |
| 2024-10-02 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-08-22 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-08-08 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-05-30 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-05-22 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-04-29 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-04-25 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-03-26 | Hochstufung | Stifel | Hold → Buy |
| 2023-08-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-05-05 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-04-24 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-01-26 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-11-15 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-08-09 | Herabstufung | Wells Fargo | Overweight → Underweight |
| 2022-03-02 | Fortgesetzt | BofA Securities | Neutral |
| 2022-01-19 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-07-21 | Fortgesetzt | Cowen | Outperform |
| 2021-05-25 | Eingeleitet | Barclays | Underweight |
| 2020-12-15 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-08-20 | Eingeleitet | Wells Fargo | Overweight |
| 2020-07-31 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-07-06 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-06-18 | Bestätigt | Raymond James | Outperform |
| 2020-04-24 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-03-23 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-06 | Eingeleitet | Raymond James | Outperform |
| 2020-02-04 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-10-18 | Eingeleitet | Guggenheim | Buy |
| 2019-10-04 | Hochstufung | UBS | Neutral → Buy |
| 2019-05-17 | Bestätigt | BofA/Merrill | Neutral |
| 2019-05-13 | Eingeleitet | SVB Leerink | Outperform |
| 2019-03-08 | Eingeleitet | BMO Capital Markets | Outperform |
| 2019-03-05 | Bestätigt | BofA/Merrill | Neutral |
| 2019-02-27 | Bestätigt | Lake Street | Buy |
| 2018-11-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2018-09-26 | Bestätigt | Dougherty & Company | Buy |
| 2018-09-26 | Bestätigt | Piper Jaffray | Overweight |
Alle ansehen
Tandem Diabetes Care Inc Aktie (TNDM) Neueste Nachrichten
Is Tandem Diabetes Care (TNDM) Undervalued Following Its Abbott Libre 3 Plus Expansion? - Yahoo Finance
Tandem’s Expanded Libre 3 Plus Integration Could Be A Game Changer For Tandem Diabetes Care (TNDM) - Sahm
Understanding the Setup: (TNDM) and Scalable Risk - Stock Traders Daily
Tandem Diabetes Care Inc. (TNDM) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Tandem Diabetes Care (TNDM) Goldman Sachs 46th Annual Global Healthcare Conference summary - Quartr
Citi Maintains Tandem Diabetes Care(TNDM.US) With Hold Rating, Maintains Target Price $17 - Moomoo
Tandem Diabetes Care (TNDM) Stifel 2024 Healthcare Conference Summary - Quartr
Does TNDM Stock Still Deserve a Place in Your Portfolio? - Yahoo Finance
Is the Market Underestimating Tandem Diabetes Care, Inc. (TNDM)’s Transition Risks? - Insider Monkey
10 Best Get Rich Quick Stocks to Buy Right Now - Insider Monkey
Tandem Diabetes Care Launches t:slim X2 Insulin Pump Compatibility With Abbott's FreeStyle Libre 3 Plus CGM Sensor - Medical Product Outsourcing
Tandem Diabetes Q1 2026 slides: record revenue, profitability returns - Investing.com
TNDMTandem Diabetes Care Inc Options - Finviz
Tandem Diabetes faces earnings test as pay-as-you-go shift weighs - Investing.com
ETFs Investing in Tandem Diabetes Care, Inc. Stocks - TradingView
TANDEM DIABETES CARE INC (TNDM) Stock Chart - ChartMill
Insulin pump makers Tandem and Insulet post contrasting Q2 results - MSN
Diabetes warning issued over insulin pump error - MSN
Tandem Diabetes Care (TNDM) Expands Compatibility with Abbott's FreeStyle Libre 3 Plus - GuruFocus
Tandem's t:slim X2 insulin pump now compatible with Abbott's FreeStyle Libre 3 Plus CGM in five countries - Medical Economics
Tandem Diabetes Care Launches t:slim X2 Insulin Pump Compatibility with Abbott FreeStyle Libre 3 Plus Sensor in Five International Markets - Yahoo Finance
Tandem Diabetes Care to Announce Second Quarter 2026 Financial Results on August 6, 2026 - Moomoo
Why Tandem Diabetes (TNDM) shares are sliding today - MSN
Why Tandem Diabetes (TNDM) Shares Are Sliding Today - Yahoo Finance
Tandem Diabetes Care, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.066666 Sh - TradingView
Why Did TNDM Stock Jump 5% After Hours Despite Q4 Earnings Miss? - Stocktwits
Press Release: Tandem Diabetes Care to Announce Second Quarter 2026 Financial Results on August 6, 2026 - 富途牛牛
The Technical Signals Behind (TNDM) That Institutions Follow - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC (TNDM) Investigation: Bronstei - The National Law Review
DexCom, Insulet gain news Buys at Deutsche Bank despite recent selloff - MSN
Tandem Diabetes Care, Inc. Actuals & Estimates (NASDAQ:TNDM) - TradingView
Tandem Diabetes Care, Inc. Actuals & Estimates (DUS:TD5A) - TradingView
TD5A Forecast — Price Target — Prediction for 2027 - TradingView
Price to earnings forward of Tandem Diabetes Care, Inc. – NASDAQ:TNDM - TradingView
Tandem Diabetes Care, Inc. Actuals & Estimates (BMV:TNDM) - TradingView
Tandem insulin pumps cleared in EU for expanded indications - MSN
Price to sales forward of Tandem Diabetes Care, Inc. – NASDAQ:TNDM - TradingView
Enterprise value to EBIT forward of Tandem Diabetes Care, Inc. – NASDAQ:TNDM - TradingView
Enterprise value to EBITDA forward of Tandem Diabetes Care, Inc. – NASDAQ:TNDM - TradingView
What Does Tandem Diabetes Care's Upsized Convertible Note Offering Mean for Investors - Kavout | AI
Tandem Diabetes Care, Inc. Actuals & Estimates (BIVA:TNDM) - TradingView
TNDM stock down following Q1 earnings & revenue beat, gross margin up - MSN
TNDM Forecast — Price Target — Prediction for 2027 - TradingView
Tandem Diabetes Care Inc (TNDM) Valuation: PE, PB & Fair Value Analysis - TradingKey
Tandem Diabetes rises on Wells Fargo upgrade - MSN
TNDM Initiated Coverage by Deutsche Bank -- Rating Set to Hold - GuruFocus
This Insulet Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
Deutsche Bank Initiates Coverage on Tandem Diabetes Care With Hold Rating, $15.50 Price Target - marketscreener.com
Tandem Diabetes Care Inc (TNDM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Tandem Diabetes Care Inc (TNDM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Tandem Diabetes Care Inc (TNDM) Institutional Confidence - TradingKey
Finanzdaten der Tandem Diabetes Care Inc-Aktie (TNDM)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):